<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04209036</url>
  </required_header>
  <id_info>
    <org_study_id>CICOG-30-10-19\48</org_study_id>
    <nct_id>NCT04209036</nct_id>
  </id_info>
  <brief_title>Can 3D Laparoscopy Improve Surgical Performances in Surgeons in Training?</brief_title>
  <official_title>2D Versus 3D Total Laparoscopic Hysterectomy by Surgeons in Training: a Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Due to the inconclusive results on the benefits of 3D laparoscopic system present in
      literature, this prospective randomised pilot study aims to assess if the operative time of
      total laparoscopic hysterectomy (TLH) for benign indication performed by trainees could be
      reduced using 3D laparoscopy instead of standard laparoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients with benign uterine pathology at preoperative examinations (pelvic ultrasound
      and/or magnetic resonance and/or CT scan) and with indication for total laparoscopic
      hysterectomy, will be enrolled in the study.

      While under general anesthesia, the patient is positioned in the dorsal lithotomic position
      with both legs supported in stirrups with a Trendelenburg tilt and arms along the body. A
      four disposable or reusable, sterile trocar transperitoneal approach is used. A 10 mm port is
      inserted at the umbilicus for the telescope. Once pneumoperitoneum (12 mmHg) is achieved,
      intra-abdominal visualization will be obtained with a 0° high-definition telescope (HD
      EndoEye 10 mm, Olympus Winter &amp; IBE GMBH, Hamburg - Germany) or with 0° 3D laparoscopy
      high-definition (Olympus Winter &amp; IBE GMBH, Hamburg - Germany). The instruments used include
      bipolar grasper, monopolar scissors, monopolar hook, various graspers and a suction
      irrigation system. Clermont Ferrand uterine manipulator (Model K.Storz Endoskope,Tuttlingen,
      Germany) is optionally used to move the uterus.

      Total hysterectomy is then performed according to standard technique used by the recruiting
      center (development of the pararectal space and identification of uterine artery, coagulation
      of ovarian pedicles, development of the vesico-uterine septum, colpotomy).The vaginal vault
      is then closed with a 0 Vycril suture laparoscopically (continuous suture).

      Detailed operative time, intra and post operative early complications will be recorded
      (Extended Clavien‑Dindo classification of surgical complications will be used for post
      operative complications)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Operative time</measure>
    <time_frame>intra-operative</time_frame>
    <description>To compare operative time for Total Laparoscopic Hysterectomy with 3D laparoscopy vs. conventional laparoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-operative complications</measure>
    <time_frame>intra-operative</time_frame>
    <description>• Evaluate the incidence of intraoperative complications in the two laparoscopic system (intraoperative blood loss, need for intraoperative transfusions, bladder lesions, ureteral lesions, vascular lesions, intestinal lesions)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early post-operative complications</measure>
    <time_frame>from surgery up to 30 days from surgery</time_frame>
    <description>Evaluate the incidence of postoperative complications (need for postoperative transfusions, dehiscence of the vaginal cuff, fever, urinary tract infections, surgical wound infections)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Uterine Fibroid</condition>
  <condition>Uterine Bleeding</condition>
  <condition>Uterine Prolapse</condition>
  <arm_group>
    <arm_group_label>3D laparoscopy arm</arm_group_label>
    <description>patients submitted to total hysterectomy using a 3D laparoscopic camera</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D laparoscopy arm</arm_group_label>
    <description>patients submitted to total hysterectomy using a 2D laparoscopic camera (standard laparoscopic camera)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>0° 3D laparoscopy high-definition camera(Olympus Winter &amp; IBE GMBH, Hamburg - Germany)</intervention_name>
    <description>total laparoscopic hysterectomy using a 3D laparoscopy high-definition system</description>
    <arm_group_label>3D laparoscopy arm</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with benign uterine pathology at preoperative examinations (pelvic ultrasound
        and / or magnetic resonance and / or abdominal CT scan) and with indication for total
        laparoscopic hysterectomy, will be enrolled in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suffering from benign uterine pathology (uterine fibromatosis, abnormal blood
             loss, complex hyperplasia with atypia, uterine prolapse) with indication for total
             uterine hysterectomy

          -  Uterine size &lt;/= than 15 cm

          -  American Society of Anesthesiologists (ASA) class &lt; 3

          -  Patient's informed consent

          -  No actual pregnancies or pelvic inflammatory disease

          -  No previous major abdominal surgical procedures

        Exclusion Criteria:

          -  Suspected neoplastic pathology

          -  Patients not eligible for surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Francesco Fanfani, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Fanfani, Professor</last_name>
    <phone>06 30154979</phone>
    <email>francesco.fanfani74@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefano Restaino, MD</last_name>
    <email>restaino.stefano@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario A. Gemelli, IRCCS</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Fanfani, Professor</last_name>
      <phone>0630154979</phone>
      <email>francesco.fanfani74@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Stefano Restaino, MD</last_name>
      <email>restaino.stefano@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Stefano Restaino, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 17, 2019</study_first_submitted>
  <study_first_submitted_qc>December 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2019</study_first_posted>
  <last_update_submitted>December 20, 2019</last_update_submitted>
  <last_update_submitted_qc>December 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Prof. Giovanni Scambia</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>3D laparoscopy</keyword>
  <keyword>2D laparoscopy</keyword>
  <keyword>surgeons in training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Uterine Hemorrhage</mesh_term>
    <mesh_term>Uterine Prolapse</mesh_term>
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

